Vincent Carey, PhD, of the Channing Division of Network Medicine, was awarded funding from the Chan Zuckerberg Initiative (CZI) through its Essential Open Source Software for Science program, which supports open source software projects that are essential to biomedical research. With a total of $5 million distributed to fund more than 40 projects, these grants support software maintenance, growth, development and community engagement for critical open source tools.
Carey, a biostatistician, designs and analyzes clinical trials in the fields of obesity, cardiovascular disease and asthma. In addition, he is a co-founder of bioconductor.org, an open-source software ecosystem for the statistical analysis of genome-scale experiments.
His winning project, “Bioconductor Build System: Continuous Integration and Developer Feedback,” aims to reengineer the Bioconductor build system for nightly continuous integration, production and distribution of tarballs and binaries for over 1,700 user-contributed software packages.
CZI, founded by Priscilla Chan, MD, and Mark Zuckerberg in 2015, is a new kind of philanthropy that brings together world-class engineering, grant-making, impact investing, and policy and advocacy work to help build an inclusive, just and healthy future for everyone. CZI supports several areas of basic science and technology, with the goal of making it possible to cure, prevent or manage all diseases by the end of this century.
